Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
26 September 2024
Legal News: International Trade Enforcement & Compliance
Five Compliance Best Practices for … Drafting Legal Terms and Conditions
Drafting clear and effective legal terms and conditions is crucial for establishing a legally binding agreements between parties while minimizing the risk of disputes or misunderstandings.
26 September 2024
Legal News: International Trade Enforcement & Compliance
What Every Multinational Company Should Know About … Implementing Compliance Audits
Most multinational companies are aware of the need for robust compliance programs consisting of risk assessments, policies, and procedures adopted to mitigate identified compliance risks, and identifying and responding to violations of policies and procedures (or laws and regulations).
26 September 2024
Viewpoints
DOJ Stresses AI Risk and Whistleblower Protection in Revised Corporate Compliance Guidance
On Monday, September 23, DOJ’s Criminal Division announced updates to its guidance for evaluating corporate compliance programs.